Matches in Nanopublications for { ?s ?p "[These results demonstrate that SERCA2 is an important target of FOG-2 and that increased FOG-2 expression may contribute to a decline in cardiac function in end-stage heart failure by impaired T3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 16 of
16
with 100 items per page.
- NP203276.RAWVAR2hr4rXfVhoYkxpW7duMz4klQKmqI5tyeEZdOHEk130_assertion description "[These results demonstrate that SERCA2 is an important target of FOG-2 and that increased FOG-2 expression may contribute to a decline in cardiac function in end-stage heart failure by impaired T3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP203276.RAWVAR2hr4rXfVhoYkxpW7duMz4klQKmqI5tyeEZdOHEk130_provenance.
- NP268088.RAf0sWbfZfg0IWEQ32XLid4OyGwzpWl_L3dv9Zf7cJTqk130_assertion description "[These results demonstrate that SERCA2 is an important target of FOG-2 and that increased FOG-2 expression may contribute to a decline in cardiac function in end-stage heart failure by impaired T3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268088.RAf0sWbfZfg0IWEQ32XLid4OyGwzpWl_L3dv9Zf7cJTqk130_provenance.
- assertion description "[These results demonstrate that SERCA2 is an important target of FOG-2 and that increased FOG-2 expression may contribute to a decline in cardiac function in end-stage heart failure by impaired T3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These results demonstrate that SERCA2 is an important target of FOG-2 and that increased FOG-2 expression may contribute to a decline in cardiac function in end-stage heart failure by impaired T3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP256386.RAaqhYBAbwGboOqDG3QTpEoqmvaiX9SEGCqygUeIJVbPM130_assertion description "[These results demonstrate that SERCA2 is an important target of FOG-2 and that increased FOG-2 expression may contribute to a decline in cardiac function in end-stage heart failure by impaired T3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256386.RAaqhYBAbwGboOqDG3QTpEoqmvaiX9SEGCqygUeIJVbPM130_provenance.
- NP872403.RAe0U9E5znSKf18OLFnZLDlBuJIZqR87MD8AYuNb6Z17A130_assertion description "[These results demonstrate that SERCA2 is an important target of FOG-2 and that increased FOG-2 expression may contribute to a decline in cardiac function in end-stage heart failure by impaired T3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP872403.RAe0U9E5znSKf18OLFnZLDlBuJIZqR87MD8AYuNb6Z17A130_provenance.
- assertion description "[These results demonstrate that SERCA2 is an important target of FOG-2 and that increased FOG-2 expression may contribute to a decline in cardiac function in end-stage heart failure by impaired T3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These results demonstrate that SERCA2 is an important target of FOG-2 and that increased FOG-2 expression may contribute to a decline in cardiac function in end-stage heart failure by impaired T3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP757665.RAE_GDGrFt5nfjK345fQHC2U2g60vHB7w0rTM-v8GUQ5Q130_assertion description "[These results demonstrate that SERCA2 is an important target of FOG-2 and that increased FOG-2 expression may contribute to a decline in cardiac function in end-stage heart failure by impaired T3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP757665.RAE_GDGrFt5nfjK345fQHC2U2g60vHB7w0rTM-v8GUQ5Q130_provenance.
- NP720667.RAHPhsrTxn0iUsvqMbhTQ45umknqvCx3dWnueS6INNPa0130_assertion description "[These results demonstrate that SERCA2 is an important target of FOG-2 and that increased FOG-2 expression may contribute to a decline in cardiac function in end-stage heart failure by impaired T3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP720667.RAHPhsrTxn0iUsvqMbhTQ45umknqvCx3dWnueS6INNPa0130_provenance.
- NP684592.RAanCV8urlsS7UVucTiBV7_P51ejaPuVNVYI_4_UZkPCo130_assertion description "[These results demonstrate that SERCA2 is an important target of FOG-2 and that increased FOG-2 expression may contribute to a decline in cardiac function in end-stage heart failure by impaired T3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP684592.RAanCV8urlsS7UVucTiBV7_P51ejaPuVNVYI_4_UZkPCo130_provenance.
- NP256378.RA9h9oi-wJ90c8k6KgwRoX3U2VzwgKzgfRcrYM0ZOQllU130_assertion description "[These results demonstrate that SERCA2 is an important target of FOG-2 and that increased FOG-2 expression may contribute to a decline in cardiac function in end-stage heart failure by impaired T3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256378.RA9h9oi-wJ90c8k6KgwRoX3U2VzwgKzgfRcrYM0ZOQllU130_provenance.
- NP684590.RAFHheyQRm6L1ahG9wz07sW2q3Lm98mE5w7fspWB6yYvU130_assertion description "[These results demonstrate that SERCA2 is an important target of FOG-2 and that increased FOG-2 expression may contribute to a decline in cardiac function in end-stage heart failure by impaired T3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP684590.RAFHheyQRm6L1ahG9wz07sW2q3Lm98mE5w7fspWB6yYvU130_provenance.
- NP684593.RALDwlMbjtQTksJKd3mxvQujhxkjsXsXDtSDpXViFB39A130_assertion description "[These results demonstrate that SERCA2 is an important target of FOG-2 and that increased FOG-2 expression may contribute to a decline in cardiac function in end-stage heart failure by impaired T3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP684593.RALDwlMbjtQTksJKd3mxvQujhxkjsXsXDtSDpXViFB39A130_provenance.
- NP872402.RAIIKcur294mCgVTxYHr_c0P12LhSaBfl-sDb62jqaHmA130_assertion description "[These results demonstrate that SERCA2 is an important target of FOG-2 and that increased FOG-2 expression may contribute to a decline in cardiac function in end-stage heart failure by impaired T3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP872402.RAIIKcur294mCgVTxYHr_c0P12LhSaBfl-sDb62jqaHmA130_provenance.
- NP684591.RA45K4p7R-HfrBgsQCvc8JO5B0RzN-UcAy62O75SkLlKA130_assertion description "[These results demonstrate that SERCA2 is an important target of FOG-2 and that increased FOG-2 expression may contribute to a decline in cardiac function in end-stage heart failure by impaired T3 signaling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP684591.RA45K4p7R-HfrBgsQCvc8JO5B0RzN-UcAy62O75SkLlKA130_provenance.